Zoetis Inc. Restructuring and Related Cost, Accelerated Depreciation
Zoetis Inc. (ZTS) reported Restructuring and Related Cost, Accelerated Depreciation of $5.00 million for the 9-month period ending 2016-10-02, per its 10-Q filed 2016-11-03.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveAcceleratedDepreciation · last filed 2016-11-03
- Zoetis Inc. restructuring and related cost, accelerated depreciation for the quarter ending 2016-10-02 was $2.00M.
- Zoetis Inc. restructuring and related cost, accelerated depreciation for the quarter ending 2016-07-03 was $2.00M.
- Zoetis Inc. restructuring and related cost, accelerated depreciation for the quarter ending 2015-12-31 was $0.00.
- Zoetis Inc. restructuring and related cost, accelerated depreciation for the quarter ending 2015-09-27 was $0.00.
- Zoetis Inc. restructuring and related cost, accelerated depreciation for fiscal 2015 was $0.00.
- Zoetis Inc. restructuring and related cost, accelerated depreciation for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- Zoetis Inc. restructuring and related cost, accelerated depreciation for fiscal 2013 was $5.00M.
- Zoetis Inc. restructuring and related cost, accelerated depreciation for fiscal 2012 was $0.00.
| Period end | Restructuring and Related Cost, Accelerated Depreciation 3 month | Restructuring and Related Cost, Accelerated Depreciation 6 month | Restructuring and Related Cost, Accelerated Depreciation 9 month | Restructuring and Related Cost, Accelerated Depreciation 12 month |
|---|---|---|---|---|
| 2016-10-02 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $4.00M derived: sum of 2 quarters · filed 2016-11-03 | $5.00M 10-Q · filed 2016-11-03 | |
| 2016-07-03 | $2.00M 10-Q · filed 2016-08-05 | $3.00M 10-Q · filed 2016-08-05 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $0.00 derived: sum of 2 quarters · filed 2016-02-24 | $0.00 derived: sum of 3 quarters · filed 2016-02-24 | $0.00 10-K · filed 2016-02-24 |
| 2015-09-27 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | -$1.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2015-06-28 | $0.00 10-Q · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | -$1.00M derived: sum of 3 quarters · filed 2016-02-24 | -$1.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2015-03-29 | $0.00 10-Q · filed 2015-05-07 | -$1.00M derived: sum of 2 quarters · filed 2016-02-24 | -$1.00M derived: sum of 3 quarters · filed 2016-02-24 | -$1.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$1.00M derived: sum of 2 quarters · filed 2016-02-24 | -$1.00M derived: sum of 3 quarters · filed 2016-02-24 | $0.00 10-K · filed 2016-02-24 |
| 2014-09-28 | $0.00 10-Q · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $1.00M 10-Q · filed 2015-11-05 | $6.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-29 | $0.00 10-Q · filed 2015-08-06 | $1.00M 10-Q · filed 2015-08-06 | $6.00M derived: sum of 3 quarters · filed 2016-02-24 | $6.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-30 | $1.00M 10-Q · filed 2015-05-07 | $6.00M derived: sum of 2 quarters · filed 2016-02-24 | $6.00M derived: sum of 3 quarters · filed 2016-02-24 | $6.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $5.00M derived: sum of 2 quarters · filed 2016-02-24 | $5.00M derived: sum of 3 quarters · filed 2016-02-24 | $5.00M 10-K · filed 2016-02-24 |
| 2013-09-29 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-13 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |